Zai Lab (ZLAB) Cash & Equivalents (2016 - 2026)

Zai Lab has disclosed Cash & Equivalents across 11 years of filings, most recently posting $1.2 million for Q1 2026.

• Cash & Equivalents for Q1 2026 came in at $1.2 million, up 4.26% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.2 million (up 4.26% YoY), and the FY2025 annual result was $679.6 million, up 58534.43% from the prior year.
• Cash & Equivalents came in at $1.2 million for Q1 2026 at Zai Lab, down from $679.6 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $1.1 billion in Q3 2022 to a low of $1.1 million in Q1 2023.
• The 5-year median for Cash & Equivalents is $1.2 million (2026), against an average of $386.3 million.
• Across the five-year window, Cash & Equivalents tumbled 99.9% in 2023 and surged 58534.43% in 2025, its largest moves.
• Zai Lab's Cash & Equivalents stood at $1.0 billion in 2022, then tumbled by 99.89% to $1.1 million in 2023, then increased by 5.36% to $1.2 million in 2024, then soared by 58534.43% to $679.6 million in 2025, then tumbled by 99.82% to $1.2 million in 2026.
• The last three Cash & Equivalents figures came in at $1.2 million (Q1 2026), $679.6 million (Q4 2025), and $1.2 million (Q3 2025), per Business Quant data.